Panbela Therapeutics, Inc. PBLA
Performance
| Periode | PBLA | ALLR | MTVA | VRAX | QNRX | DRMA | PALI | NUWE |
|---|---|---|---|---|---|---|---|---|
| 6M | -96.35 % | 112.69 % | -45.65 % | -33.80 % | 173.86 % | 429.34 % | 164.06 % | -90.93 % |
| YTD | -97.53 % | 37.39 % | -52.61 % | -69.45 % | 2 053.39 % | 208.27 % | -1.08 % | -93.19 % |
| 1Y | -96.92 % | 6.64 % | -60.47 % | -62.70 % | 2 735.29 % | 232.17 % | -46.04 % | -94.12 % |
| 3Y | -100.00 % | -100.00 % | -60.47 % | -95.83 % | -29.53 % | -97.49 % | -97.42 % | -99.99 % |
| 5Y | -100.00 % | -100.00 % | -60.47 % | -99.63 % | -98.92 % | -99.66 % | -99.94 % | -100.00 % |
| 10Y | -100.00 % | -100.00 % | -60.47 % | -99.63 % | -99.91 % | -99.66 % | -100.00 % | -100.00 % |
| From the beginning | -100.00 % | -100.00 % | -60.47 % | -99.63 % | -99.91 % | -99.66 % | -100.00 % | -100.00 % |